Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …

Autoimmune liver diseases are chronic inflammatory hepatobiliary disorders that when
classically defined encompass three distinctive clinical presentations; primary biliary …

Primary biliary cholangitis is an autoimmune liver disease that predominantly affects women.
It is characterised by a chronic and destructive, small bile duct, granulomatous lymphocytic …

Hong You1· Xiong Ma2· Cumali Efe3· Guiqiang Wang4· Sook‑Hyang Jeong5· Kazumichi
Abe6· Weijia Duan1· Sha Chen1· Yuanyuan Kong7· Dong Zhang8· Lai Wei9· Fu‑Sheng …

Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease
characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the …

METHODS: The patient cohort from the GLOBAL PBC Study Group was used, comprising of
long-term follow-up data from European and North American centers. Ursodeoxycholic acid …

Abstract Primary Biliary Cholangitis (PBC) is an uncommon, chronic, cholangiopathy of
autoimmune origin and unknown etiology characterized by positive anti-mitochondrial …

Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease that may
progress to fibrosis and/or cirrhosis. Treatment options are currently limited. The first-line …

Cholestasis describes impairment in bile formation or flow which can manifest clinically with
fatigue, pruritus, and jaundice. The differential diagnosis of cholestatic liver diseases is …

Primary biliary cholangitis (PBC) is an immune-mediated cholestatic liver disease mainly
diagnosed in middle-aged women, with a female-to-male ratio between 4 to 5: 1 and 9 to 10 …